How many insider trades does FilingIQ track for FTRE?

FilingIQ tracks 154 Form 4 insider transactions for FTRE (Fortrea Holdings Inc.), covering filings from Jun 20, 2023 onwards. 25 of those were filed in the last 90 days.

Are FTRE insiders net buyers or net sellers?

Across the full Form 4 history for FTRE, 7 transactions (5%) were open-market purchases and 34 (22%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does FTRE insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is FTRE in?

Fortrea Holdings Inc. (FTRE) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $889.81M.

FTRE insider trading

Healthcare

Fortrea Holdings Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

154

Last 90 days

Buys / sells

5% / 22%

Market cap

$889.81M

About Fortrea Holdings Inc.

Fortrea Holdings Inc., a contract research organization, provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers worldwide. It offers clinical services that provides development and consulting services to clinical pharmacology and clinical development spectrum. The company also offers delivery models that include full service, functional service provider, and hybrid service structures. In addition, it delivers phase I IV clinical trial management, clinical pharmacology, and consulting services. Fortrea Holdings Inc. enters into a strategic collaboration with Emery Pharma to provide rapid lot-by-lot, 1-methyl-4-nitrosopiperazine (MNP) testing of rifampin, the preferred drug for drug-drug interaction studies, to certify impurities are below the Acceptable Intake Limit set by U.S. Food and Drug Administration guidelines. The company has a strategic collaboration with SCT Cell Manufacturing s.r.o. to streamline development, accelerate timelines and bring advanced therapies to patients faster. Fortrea Holdings Inc. was incorporated in 2023 and is headquartered in Durham, North Carolina.

Company website: www.fortrea.com

FTRE insider activity at a glance

FilingIQ has scored 154 insider transactions for FTRE since Jun 20, 2023. The most recent filing in our index is dated Mar 20, 2026.

Across the full history, 7 open-market purchases and 34 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on FTRE insider trades is 58.3/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live FTRE trades on FilingIQ Raw filings on SEC EDGAR

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Frequently asked

How many insider trades does FilingIQ track for FTRE?: FilingIQ tracks 154 Form 4 insider transactions for FTRE (Fortrea Holdings Inc.), covering filings from Jun 20, 2023 onwards. 25 of those were filed in the last 90 days.
Are FTRE insiders net buyers or net sellers?: Across the full Form 4 history for FTRE, 7 transactions (5%) were open-market purchases and 34 (22%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does FTRE insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is FTRE in?: Fortrea Holdings Inc. (FTRE) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $889.81M.

Methodology & sources

Every FTRE insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.